|
| 37245145 | RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights. | J Invest Dermatol | 2023 |
| 35266292 | The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery. | Am J Med Genet A | 2022 |
| 34237445 | Lessons learned from drug trials in neurofibromatosis: A systematic review. | Eur J Med Genet | 2021 |
| 33903738 | Identifying challenges in neurofibromatosis: a modified Delphi procedure. | Eur J Hum Genet | 2021 |
| 32814709 | Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry. | JCI Insight | 2020 |
| 31793149 | Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors. | EMBO Mol Med | 2020 |
| 30908866 | From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis. | Am J Med Genet A | 2019 |
| 31836719 | Engaging a community to enable disease-centric data sharing with the NF Data Portal. | Sci Data | 2019 |
| 29681099 | 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. | Am J Med Genet A | 2018 |
| 29695767 | Cutaneous neurofibromas in the genomics era: current understanding and open questions. | Br J Cancer | 2018 |
| 26854064 | Neurofibromatosis as a gateway to better treatment for a variety of malignancies. | Prog Neurobiol | 2017 |
| 28436162 | The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis. | Am J Med Genet A | 2017 |
| 28398289 | A high-throughput molecular data resource for cutaneous neurofibromas. | Sci Data | 2017 |
| 28938910 | Creating a data resource: what will it take to build a medical information commons? | Genome Med | 2017 |
| 29117388 | Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. | J Natl Cancer Inst | 2017 |
| 28644838 | Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study. | PLoS One | 2017 |
| 28743783 | Rethinking the nonprofit foundation: an emerging niche in the rare disease ecosystem. | EMBO Mol Med | 2017 |
| 27155140 | The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway. | Am J Med Genet A | 2016 |
| 27845557 | The National Disease Research Interchange and Collaborators on: What Are the Major Hurdles to the Recovery of Human Tissue to Advance Research? | Biopreserv Biobank | 2016 |
| 25940629 | NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning. | Nucleic Acids Res | 2015 |
| 25900621 | The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach. | Am J Med Genet A | 2015 |
| 25847770 | Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway. | Eur J Med Chem | 2015 |
| 24443315 | CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. | Am J Med Genet A | 2014 |
| 25255738 | Update from the 2013 International Neurofibromatosis Conference. | Am J Med Genet A | 2014 |
| 23619303 | Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells. | Mol Cancer Ther | 2013 |
| 23825539 | Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts. | PLoS One | 2013 |
| 22072503 | In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines. | Int J Cancer | 2012 |
| 23284888 | A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells. | PLoS One | 2012 |
| 20426768 | Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. | Biosci Rep | 2011 |
| 21321483 | β-catenin and Gli1 are prognostic markers in glioblastoma. | Cancer Biol Ther | 2011 |
| 19545421 | KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain? | BMC Cancer | 2009 |
| 19434656 | How to achieve confidence in drug discovery and development: managing risk (from a reductionist to a holistic approach). | ChemMedChem | 2009 |
| 18444511 | Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach. | Pharmazie | 2008 |
| 16608734 | Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes). | J Drug Target | 2006 |
| 17718951 | Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: toxicity, in vitro transfection and in vivo delivery. | J Control Release | 2006 |
| 17718950 | Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: dendrimer synthesis, stability and oligonucleotide complexation. | J Control Release | 2006 |
| 16307379 | Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. | Biosci Rep | 2005 |
| 15136766 | Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles. | Cancer Biol Ther | 2004 |
| 15557753 | Alteration of frizzled expression in renal cell carcinoma. | Tumour Biol | 2004 |
| 15527325 | Housekeeping genes as internal standards in cancer research. | Mol Diagn | 2004 |